TRx0237
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for TRx0237, covering 2014-07-11 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment [Phase 3]